AEHR trades 147.3% below Wall Street's consensus target of $132.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AEHR achieves its forward estimates and maintains a stable P/E multiple of 70.7x. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, Aehr Test Systems (AEHR) has a Wall Street consensus price target of $132.50, based on estimates from 5 covering analysts. With the stock currently trading at $53.57, this represents a potential upside of +147.3%. The company has a market capitalization of $1.68B.
Analyst price targets range from a low of $110.00 to a high of $175.00, representing a 49% spread in expectations. The median target of $122.50 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, AEHR trades at a trailing P/E of 839.7x and forward P/E of 70.7x. Analysts expect EPS to grow +1088.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $4.95, with bear and bull scenarios of $3.12 and $6.53 respectively. Model confidence stands at 48/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 COHUCohu, Inc. | $1.8B | $38.49 | $77.40 | +101.1% | Buy | 36.2x | 14 |
 ACLSAxcelis Technologies, Inc. | $3.1B | $99.24 | $140.00 | +41.1% | Buy | 24.2x | 13 |
 ONTOOnto Innovation Inc. | $8.6B | $173.28 | $391.11 | +125.7% | Buy | 21.4x | 12 |
 ICHRIchor Holdings, Ltd. | $1.1B | $30.97 | $78.75 | +154.3% | Buy | 17.2x | 14 |
 FORMFormFactor, Inc. | $6.3B | $81.12 | $160.00 | +97.2% | Buy | 24.0x | 20 |
 KLICKulicke and Soffa Industries, Inc. | $3.3B | $64.01 | $62.50 | -2.4% | Buy | 16.6x | 11 |
 MKSIMKS Inc. | $13.0B | $192.27 | $401.86 | +109.0% | Buy | 14.6x | 29 |
 CAMTCamtek Ltd. | $4.5B | $97.05 | $170.71 | +75.9% | Buy | 26.8x | 13 |
 PLABPhotronics, Inc. | $1.6B | $27.36 | $42.25 | +54.4% | Buy | 13.6x | 11 |
 WOLFWolfspeed Inc. | $1.2B | $23.79 | $25.00 | +5.1% | Hold | — | 19 |
Quick answers to the most common questions about buying AEHR stock.
The consensus Wall Street price target for AEHR is $132.5, representing 147.3% upside from the current price of $53.57. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AEHR has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $132.5 implies 147.3% upside from current levels.
At a forward P/E of 70.6728x, AEHR trades at a premium valuation. The consensus price target of $132.5 (147.3% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $175 for AEHR, while the most conservative target is $110. The consensus of $132.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $7 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
AEHR is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AEHR stock forecast based on 5 Wall Street analysts shows a consensus price target of $132.5, with estimates ranging from $110 (bear case) to $175 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $5, with bear/bull scenarios of $3/$7.
Our quantitative valuation model calculates AEHR's fair value at $5 (base case), with a bear case of $3 and bull case of $7. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 48/100.
AEHR trades at a forward P/E ratio of 70.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 839.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on AEHR, with a "Buy" consensus rating and $132.5 price target (147.3% upside). 3 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AEHR analyst price targets range from $110 to $175, a 49% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $132.5 consensus represents the middle ground. Our model's $3-$7 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.